If you need more lookups,
subscriptions start at $34 USD/month.
Eric Richman Location
Potomac, MD, US
Eric Richman Work
2025 -now Independent Director @
2020 -now Director @
2017 -now Independent Director @
2024 -now Independent Director @
2022 -now Independent Director @
2020 -now Director @
2020 -now Chief Executive Officer @
2018 -2020 Director @
2008 -2020 Director @
2019 -now Director and Co-Founder @ Horizon Infusions Infuse Holdings
2019 -now Director @
2016 -2018 Venture Partner @
2018 -now Independant Director @ Novelstem International Corp
2016 -2018 Director and Chief Executive Officer @
2017 -now Chairman @
2010 -2017 President and Chief Executive Officer @
2009 -2013 Director @
2004 -2008 Director @ Lev Pharmaceuticals
2000 -2001 Director @
1996 -2000 Director, International Commercialization @
1993 -1996 Senior Product Director @
1988 -1993 Strategic Planning @
1987 -1988 Associate @
Eric Richman Education
Thunderbird
Master Of Business Administration (Marketing, Finance)
1986-1987
Sophie Davis School of Biomedical Education
Bachelor Of Science (Biomedical Science)
1980-1985
Eric Richman Skills
Molecular Biology
Oncology
Vaccines
Strategic Planning
Lifesciences
Clinical Trials
Biotechnology
Venture Capital
Pharmaceutical Industry
Due Diligence
Technology Transfer
Mergers & Acquisitions
Strategy
CRO
Commercialization
Biopharmaceuticals
Life Sciences
Marketing
Mergers and Acquisitions
Public Speaking
Research
Business Analysis
Eric Richman Summary
Eric Richman, based in Potomac, MD, US, is currently a Independent Director at SafeHeal. Eric Richman brings experience from previous roles at Gain Therapeutics, LabConnect, PolarityBio and MicroHealth (digital hematology). Eric Richman holds a 1986 - 1987 Master Of Business Administration in Marketing, Finance @ Thunderbird. With a robust skill set that includes Molecular Biology, Oncology, Vaccines, Strategic Planning, Lifesciences and more. Eric Richman has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Eric Richman?
Find contact details for 700 million professionals.